Xometry, Inc. and Subsidiaries | ||||||||
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss | ||||||||
(In thousands, except share and per share amounts) | ||||||||
Three Months Ended
March 31, | ||||||||
2023 | 2022 | |||||||
(unaudited) | ||||||||
Revenue | $ | 105,326 | $ | 83,671 | ||||
Cost of revenue | 65,957 | 50,732 | ||||||
Gross profit | 39,369 | 32,939 | ||||||
Sales and marketing | 22,439 | 19,285 | ||||||
Operations and support | 12,608 | 12,358 | ||||||
Product development | 8,125 | 7,290 | ||||||
General and administrative | 15,957 | 12,959 | ||||||
Impairment of assets | 27 | - | ||||||
Total operating expenses | 59,156 | 51,892 | ||||||
Loss from operations | (19,787 | ) | (18,953 | ) | ||||
Other (expenses) income | ||||||||
Interest expense | (1,198 | ) | (769 | ) | ||||
Interest and dividend income | 2,695 | 96 | ||||||
Other income (expenses) | 17 | (962 | ) | |||||
Income from unconsolidated joint venture | 66 | 34 | ||||||
Total other income (expenses) | 1,580 | (1,601 | ) | |||||
Loss before income taxes | (18,207 | ) | (20,554 | ) | ||||
Provision (benefit) for income taxes | (136 | ) | 559 | |||||
Net loss | (18,343 | ) | (19,995 | ) | ||||
Net income attributable to noncontrolling interest | 1 | 17 | ||||||
Net loss attributable to common stockholders | $ | (18,344 | ) | $ | (20,012 | ) | ||
Net loss per share, basic and diluted | $ | (0.38 | ) | $ | (0.43 | ) | ||
Weighted-average number of shares outstanding used to compute
net loss per share, basic and diluted | 47,699,561 | 46,789,585 | ||||||
Comprehensive loss: | ||||||||
Foreign currency translation | $ | 135 | $ | (28 | ) | |||
Total other comprehensive income (loss) | 135 | (28 | ) | |||||
Net loss | (18,343 | ) | (19,995 | ) | ||||
Comprehensive loss | (18,208 | ) | (20,023 | ) | ||||
Comprehensive income attributable to noncontrolling interest | 5 | 34 | ||||||
Total comprehensive loss attributable to common stockholders | $ | (18,213 | ) | $ | (20,057 | ) | ||